Loading...

Post-market safety warnings for drugs approved in Canada under the Notice of Compliance with conditions policy

AIMS: Health Canada has developed a pathway to approve drugs that have limited efficacy and safety data, the Notice of Compliance with conditions (NOC/c) policy. Increased safety reporting is required for these drugs but there has not been any systematic review of their post-market safety. This stud...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Clin Pharmacol
Hovedforfatter: Lexchin, Joel
Format: Artigo
Sprog:Inglês
Udgivet: BlackWell Publishing Ltd 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4415721/
https://ncbi.nlm.nih.gov/pubmed/25393960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12552
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!